CLINICAL_TRIALS
trial_result
· 2022-01-06
Clinical Trial Update: Evaluating Precision of Therapy - Milrinone [Phase 2]
Summary
Phase 2 clinical trial update evaluating milrinone for congenital heart disease has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The Hospital for Sick Children | Conditions: Congenital Heart Disease | Phase 2 | Status: COMPLETED